Cargando…
RNF2 Mediates Hepatic Stellate Cells Activation by Regulating ERK/p38 Signaling Pathway in LX-2 Cells
The therapeutic approach of liver fibrosis is still an unsolved clinical problem worldwide. Notably, the accumulation of extracellular matrix (ECM) in the liver is mediated by the production of cytokines and growth factors, such as transforming growth factor-β1 (TGF-β1) in hepatic stellate cells (HS...
Autores principales: | Yan, Qi, Pan, Linxin, Qi, Shunli, Liu, Fang, Wang, Zhen, Qian, Cheng, Chen, Lijian, Du, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015948/ https://www.ncbi.nlm.nih.gov/pubmed/33816485 http://dx.doi.org/10.3389/fcell.2021.634902 |
Ejemplares similares
-
Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020) -
Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
por: Weiskirchen, Ralf, et al.
Publicado: (2013) -
Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells
por: Wang, Cong, et al.
Publicado: (2020) -
MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression
por: Wang, Qi, et al.
Publicado: (2020) -
Tunicamycin Induces Hepatic Stellate Cell Apoptosis Through Calpain-2/Ca(2 +)-Dependent Endoplasmic Reticulum Stress Pathway
por: Liu, Haiying, et al.
Publicado: (2021)